EP1234030A4 - 18 proteines secretees humaines - Google Patents

18 proteines secretees humaines

Info

Publication number
EP1234030A4
EP1234030A4 EP00978592A EP00978592A EP1234030A4 EP 1234030 A4 EP1234030 A4 EP 1234030A4 EP 00978592 A EP00978592 A EP 00978592A EP 00978592 A EP00978592 A EP 00978592A EP 1234030 A4 EP1234030 A4 EP 1234030A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00978592A
Other languages
German (de)
English (en)
Other versions
EP1234030A2 (fr
Inventor
Steven M Ruben
George A Komatsoulis
Kevin P Baker
Paul E Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1234030A2 publication Critical patent/EP1234030A2/fr
Publication of EP1234030A4 publication Critical patent/EP1234030A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP00978592A 1999-11-19 2000-11-15 18 proteines secretees humaines Withdrawn EP1234030A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16641599P 1999-11-19 1999-11-19
US166415P 1999-11-19
US21513600P 2000-06-30 2000-06-30
US215136P 2000-06-30
PCT/US2000/031162 WO2001036432A2 (fr) 1999-11-19 2000-11-15 18 proteines secretees humaines

Publications (2)

Publication Number Publication Date
EP1234030A2 EP1234030A2 (fr) 2002-08-28
EP1234030A4 true EP1234030A4 (fr) 2003-05-07

Family

ID=26862246

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00978592A Withdrawn EP1234030A4 (fr) 1999-11-19 2000-11-15 18 proteines secretees humaines

Country Status (5)

Country Link
EP (1) EP1234030A4 (fr)
JP (1) JP2003514541A (fr)
AU (1) AU1604401A (fr)
CA (1) CA2388777A1 (fr)
WO (1) WO2001036432A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088386B2 (en) * 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
US7419663B2 (en) 1998-03-20 2008-09-02 Genentech, Inc. Treatment of complement-associated disorders
US7192589B2 (en) 1998-09-16 2007-03-20 Genentech, Inc. Treatment of inflammatory disorders with STIgMA immunoadhesins
DE60139720D1 (de) 2000-06-28 2009-10-08 Glycofi Inc Verfahren für die Herstellung modifizierter Glykoproteine
US7625756B2 (en) 2000-06-28 2009-12-01 GycoFi, Inc. Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
US7598055B2 (en) 2000-06-28 2009-10-06 Glycofi, Inc. N-acetylglucosaminyltransferase III expression in lower eukaryotes
US7449308B2 (en) 2000-06-28 2008-11-11 Glycofi, Inc. Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
CA2420140A1 (fr) * 2000-08-24 2002-02-28 Genentech, Inc. Compositions et procedes de diagnostic et traitement de tumeurs
AU2003258714A1 (en) * 2002-09-06 2004-03-29 Cytos Biotechnology Ag Immune modulatory compounds and methods
US7332299B2 (en) 2003-02-20 2008-02-19 Glycofi, Inc. Endomannosidases in the modification of glycoproteins in eukaryotes
JP4897690B2 (ja) * 2004-10-12 2012-03-14 ジェネンテック， インコーポレイテッド 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド
NZ567483A (en) 2005-11-04 2012-04-27 Genentech Inc Use of complement pathway inhibitors to treat ocular diseases
US7776573B2 (en) 2006-06-01 2010-08-17 Genentech, Inc. Crystal structure of CRIg and C3b:CRIg complex
EP2907827B1 (fr) 2006-11-02 2018-09-19 Genentech, Inc. Anticorps humanisés anti-facteur D et leurs utilisations
AR066660A1 (es) 2007-05-23 2009-09-02 Genentech Inc Prevencion y tratamiento de condiciones del ojo asociadas con su complemento
CR20170001A (es) 2008-04-28 2017-08-10 Genentech Inc Anticuerpos anti factor d humanizados
JP5836800B2 (ja) 2008-05-06 2015-12-24 ジェネンテック， インコーポレイテッド 親和性成熟ＣＲＩｇ変異体
KR101137019B1 (ko) * 2009-05-25 2012-05-24 한국생명공학연구원 신규한 ｇｐｃｒ 단백질 및 이의 용도
MX2012011688A (es) 2010-04-09 2012-11-23 Amgen Inc Proteinas btnl9, acidos nucleicos y anticuerpos y usos de los mismos.
SG11201601044XA (en) 2013-08-12 2016-03-30 Genentech Inc Compositions and method for treating complement-associated conditions
MA39934A (fr) 2014-05-01 2017-03-08 Hoffmann La Roche Variants d'anticorps anti-facteur d et leurs utilisations
US10407510B2 (en) 2015-10-30 2019-09-10 Genentech, Inc. Anti-factor D antibodies and conjugates
CN108472382A (zh) 2015-10-30 2018-08-31 豪夫迈·罗氏有限公司 抗-因子d抗体变体缀合物及其用途
WO2017150681A1 (fr) * 2016-03-03 2017-09-08 東亞合成株式会社 Procédé de diagnostic de sclérose latérale amyotrophique utilisant un peptide signal comme index

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001023546A1 (fr) * 1999-09-27 2001-04-05 Human Genome Sciences, Inc. 37 proteines secretees humaines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001550A1 (fr) * 1997-07-03 1999-01-14 Dana-Farber Cancer Institute Procede de detection de modifications de msh5
JPH11313673A (ja) * 1998-04-30 1999-11-16 Hoechst Marion Roussel Kk ヒトｂｍｐ−２プロモーターおよびこれを用いた骨関連物質の探索法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001023546A1 (fr) * 1999-09-27 2001-04-05 Human Genome Sciences, Inc. 37 proteines secretees humaines

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BOLL WERNER ET AL: "Messenger RNAs expressed in intestine of adult but not baby rabbits: Isolation of cognate cDNAs and characterization of a novel brush border protein with esterase and phospholipase activity", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 268, no. 17, 15 June 1993 (1993-06-15), pages 12901 - 12911, XP002200728, ISSN: 0021-9258 *
DATABASE EMBL [online] 11 October 1999 (1999-10-11), BIRREN ET AL.: "Homo sapiens clone RP11-13H7, WORKING DRAFT SEQUENCE, 7 unordered pieces", XP002220028, Database accession no. AC011640 *
See also references of WO0136432A3 *

Also Published As

Publication number Publication date
WO2001036432A2 (fr) 2001-05-25
JP2003514541A (ja) 2003-04-22
WO2001036432A3 (fr) 2002-05-10
CA2388777A1 (fr) 2001-05-25
AU1604401A (en) 2001-05-30
EP1234030A2 (fr) 2002-08-28

Similar Documents

Publication Publication Date Title
EP1218408A4 (fr) 32 proteines humaines secretees
EP1212343A4 (fr) 52 proteines humaines secretees
EP1181390A4 (fr) 27 proteines humaines secretees
EP1234030A4 (fr) 18 proteines secretees humaines
EP1224285A4 (fr) 27 proteines humaines secretees
EP1212342A4 (fr) 18 proteines secretees humaines
EP1226231A4 (fr) 19 proteines humaines secretees
EP1175438A4 (fr) Soixante-deux prot ines humaines s cr t es
EP1192278A4 (fr) 48 proteines secretees humaines
EP1192176A4 (fr) 49 proteines secretees humaines
EP1165827A4 (fr) 45 proteines humaines secretees
EP1175439A4 (fr) 49 proteines humaines secretees
EP1159284A4 (fr) 33 proteines humaines secretees
EP1189917A4 (fr) 48 proteines humaines secretees
EP1185543A4 (fr) 50 proteines humaines secretees
EP1173477A4 (fr) 49 proteines humaines secretees
EP1224201A4 (fr) 32 proteines humaines secretees
EP1203005A4 (fr) 25 proteines secretees humaines
EP1165602A4 (fr) 49 proteines secretees par un etre humain
EP1171460A4 (fr) 48 proteines secretees humaines
EP1169332A4 (fr) Proteines humaines secretees (49)
EP1144614A4 (fr) Proteines humaines secretees (33)
EP1165828A4 (fr) 50 proteines humaines secretees
EP1185285A4 (fr) 49 proteines secretees humaines
EP1228082A4 (fr) Proteines humaines secretees 29

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020619

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: HUMAN GENOME SCIENCES, INC.

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 15/11 A, 7C 12Q 1/68 B, 7C 12N 15/00 B, 7C 07K 14/47 B

A4 Supplementary search report drawn up and despatched

Effective date: 20030321

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061026